2TACK J, TALLEY N J, CAMILLERI M, et al. Functional Gastroduodenal Disorders. In Rome Ⅲ:the functional gastrointertinal disorders [M]. Drossman DA(editor) ,2006,419.
3TALLEY NJ (American Gastroenterological Association). American gastroenterological association medical position Statement:evaluation of dyspepsia[ J ]. Gastroentorol,2005,129 : 1753.
5Rhind JA, Watson L. Gallstone dyspepsia. Br Med J, 1968, 1:32.
6Tack J, Talley N J, Camilleri M, et al, Functional Gastroduodenal Disorders, In: Drossman DA, eds, Rome Ⅲ : the functional gastrointestinal disorders, McLean, VA: Degnon and Associates, 2006, 419-486.
7Talley NJ, Zinsmeister AR, Sehleek CD, et al. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology, 1992, 102:1259-1268.
8Bolling-Sternevald E, Carlsson R, Aalykke C, et al. Self-administered symptom questionnaires in patients with dyspepsia and their yield in discriminating between endoscopic diagnoses. Dig Dis, 2002, 20:191-198.
9Zuckerman MJ, Guerra LG, Drossman DA, et al, Health-careseeking behaviors related to bowel complaints, Hispanics versus non-Hispanic whites, Dig Dis Sci, 1996, 41:77-82.
10Quartero AO, de Wit NJ, Lodder AC, et al. Disturbed solidphase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci, 1998, 43:2028-2033.
10Hohmann C, Gsehossmann J, Mark P, el al. A randomized place- bo-eontrolled trial of simethicone and eisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther. 2002,16(9) :1641-1648.
